INSIGHTS ON CLINICAL TRIAL DESIGN

• Why Should Site Agility Be Your Next Competitive Advantage?

  Maximize your trial agility by replacing slow, linear start-ups with parallel workflows and rapid SLAs. Partnering with agile sites secures a commercial edge and predictable timelines.

• Mergers And Acquisitions: How Institutional Knowledge Protecting Value

  M&A transitions can either preserve momentum or create costly setbacks. Learn how protecting institutional knowledge helps sponsors reduce risk, maintain continuity, and accelerate development.

• Why Clinical Trial Demographics Don't Match Real-World Populations

  Representative trial demographics reduce bias, strengthen safety insights, and ensure therapies work for all. Learn why diversity is essential for accurate data and better health outcomes.

• DCTs And Community-Based Research Execution And Compliance

  The FDA's regulatory endorsement of DCTs enhances their credibility, offering a pathway to more inclusive and accessible clinical research that benefits both patients and sponsors.

• Improving The Patient Experience In Clinical Research

  2/6/2025

  To preserve the quality of care and build a more effective approach to trial design, a sponsor must consider their approach to patient recruitment and enrollment early and often.

• Understanding The FDA's Push For More Representation In Clinical Trials

  1/28/2025

  Take action to improve diversity in clinical trials by addressing underrepresentation and ensuring equitable access to medical interventions, as emphasized by the FDA’s new 2025 guidance.

• The Perfect Solution For Recruitment, Retention, And ROI

  8/15/2024

  See how Citeline Connect was deployed to advance enrollment six months ahead of schedule for a sponsor’s Phase IV atopic dermatitis trial and build a community of engaged patients.

• Rapid Expansion Of Peptide And Nanobody Drug Conjugates

  7/21/2026

  Peptide and nanobody drug conjugates are gaining momentum, with 106 active programs identified globally. Learn more about the fast-evolving space for targeted drug delivery and competitive opportunities.

• How The Right Meetings Make Patient-Centered Trial Design Possible

  7/30/2025

  Including patients in trial design improves recruitment, retention, and site experience. Explore practical ways sponsors can gather early input—without disrupting timelines or adding complexity.